This announcement is a separate document:
アステラス製薬：アステラス製薬は、進行した胃がんと消化器がんの治療におけるゾルベツキシマブと化学療法の併用について、CHMPで肯定的な意見を受けています
Astellas Pharma: Astellas Pharma has received a positive opinion from the CHMP regarding the combination of zolbetuximab and chemotherapy in the treatment of advanced gastric and gastrointestinal cancers.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.